What is the equivalent oral haloperidol dose for a 100 mg monthly injection of haloperidol decanoate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Converting 100mg Haloperidol Decanoate Monthly to Oral Haloperidol

To convert 100mg monthly haloperidol decanoate to oral haloperidol, divide by 10-15, yielding approximately 5-10mg oral haloperidol daily.

FDA-Approved Conversion Method

The FDA label specifies that the maintenance dose of haloperidol decanoate should be 10-15 times the previous daily oral haloperidol dose. 1 Therefore, working backward:

  • 100mg haloperidol decanoate monthly ÷ 10 = 10mg oral haloperidol daily
  • 100mg haloperidol decanoate monthly ÷ 15 = 6.7mg oral haloperidol daily

The equivalent oral dose range is approximately 6.7-10mg daily, with 7-10mg being the most commonly used conversion. 1

Supporting Research Evidence

Multiple pharmacokinetic studies confirm this conversion ratio:

  • A 1987 study found the mean ratio of long-acting to daily oral doses during maintenance therapy ranged from 9.4:1 to 15:1 (mean 14.1:1). 2 This supports using a divisor of 10-15 for the reverse conversion.

  • A 1986 clinical trial demonstrated that haloperidol decanoate administered monthly at 9.4-15 times the daily oral dose was at least as efficacious as oral haloperidol. 3

  • A 1997 SPECT study suggested that 50mg haloperidol decanoate every 4 weeks (1 week post-injection) corresponds to approximately 4.5mg/day oral haloperidol. 4 Extrapolating linearly, 100mg monthly would equal approximately 9mg daily oral haloperidol.

Clinical Context and Caveats

Important considerations when performing this conversion:

  • The FDA label emphasizes that haloperidol decanoate produces lower plasma concentrations than equivalent oral dosing, yet maintains therapeutic efficacy. 1 This means the patient may have been adequately controlled on what appears to be a "lower" equivalent oral dose.

  • Plasma haloperidol concentrations from decanoate formulations are sustained but lower than peak concentrations from oral dosing. 2, 3 The decanoate formulation provides more stable drug levels throughout the dosing interval.

  • If converting a patient from decanoate back to oral therapy, starting at 7-10mg daily oral haloperidol is appropriate, with close monitoring for symptom recurrence. 1

  • For elderly or debilitated patients, the FDA recommends using the lower end of the conversion range (10:1 ratio), suggesting 10mg daily oral haloperidol for a 100mg monthly decanoate dose. 1

Practical Algorithm for Conversion

Step 1: Divide the monthly decanoate dose by 10-15 to estimate daily oral equivalent 1

  • 100mg ÷ 10 = 10mg daily
  • 100mg ÷ 15 = 6.7mg daily

Step 2: Consider patient factors:

  • Standard adult: Use 7-10mg daily oral haloperidol 1
  • Elderly/debilitated: Use 6.7-7mg daily oral haloperidol (closer to 10:1 ratio) 1
  • High-dose tolerant patients: May use up to 10mg daily 1

Step 3: Monitor closely during the first 2-4 weeks for:

  • Symptom recurrence (may indicate need for higher oral dose) 1
  • Extrapyramidal symptoms (oral dosing produces higher peak levels) 5
  • QT prolongation if using higher doses 5

Step 4: Adjust based on clinical response, recognizing that oral haloperidol can be titrated more rapidly than decanoate formulations 1

References

4
Research

D2-dopamine-receptor occupancy during treatment with haloperidol decanoate.

European archives of psychiatry and clinical neuroscience, 1997

5
Guideline

Haloperidol Dosing and Safety for Adult Agitation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the duration of effect of intramuscular haloperidol (Haldol) in a patient?
What is the oral haloperidol dose equivalent to a 300 mg (3 mL) dose of haloperidol decanoate?
What oral dose of haldol (haloperidol) is equivalent to a 5 mg short‑acting intramuscular dose?
What dose in milligrams of haloperidol long‑acting injectable (Haldol) is appropriate for a patient stable on 15 mg of oral haloperidol daily?
Can I give haloperidol decanoate 200 mg intramuscularly as a single long‑acting injection?
Should I start rosuvastatin at 10 mg or 20 mg daily?
How should I manage a patient with ferritin 60 ng/mL, transferrin saturation 21 %, total iron‑binding capacity 398 µg/dL, who has been on oral ferrous sulfate for 14 months and now has a recent small gastrointestinal bleed?
What is the recommended treatment plan after serotonin syndrome has resolved?
A patient diagnosed with post‑bariatric hypoglycemia is being treated with diazoxide 25 mg three times daily, which appears effective; is this diagnosis likely incorrect and should she obtain a second endocrine opinion?
How should phosphatidylcholine, L‑carnitine orotate, and silymarin be used in the management of fatty liver disease?
What is the recommended minocycline dose per kilogram of body weight?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.